Methamphetamine is a potent central nervous system (CNS) stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity.
| FactSnippet No. 624,311 |
Methamphetamine is a potent central nervous system (CNS) stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity.
| FactSnippet No. 624,311 |
Methamphetamine is neurotoxic to human midbrain dopaminergic neurons at high doses.
| FactSnippet No. 624,312 |
Methamphetamine has been shown to have a higher affinity and, as a result, higher toxicity toward serotonergic neurons than amphetamine.
| FactSnippet No. 624,313 |
Methamphetamine belongs to the substituted phenethylamine and substituted amphetamine chemical classes.
| FactSnippet No. 624,314 |
Methamphetamine is sometimes prescribed off label for narcolepsy and idiopathic hypersomnia.
| FactSnippet No. 624,315 |
Methamphetamine hydrochloride dispensed in the United States is required to include a boxed warning regarding its potential for recreational misuse and addiction liability.
| FactSnippet No. 624,316 |
Methamphetamine is often used recreationally for its effects as a potent euphoriant and stimulant as well as aphrodisiac qualities.
| FactSnippet No. 624,317 |
Methamphetamine is contraindicated in individuals with a history of substance use disorder, heart disease, or severe agitation or anxiety, or in individuals currently experiencing arteriosclerosis, glaucoma, hyperthyroidism, or severe hypertension.
| FactSnippet No. 624,318 |
Methamphetamine use has a high association with anxiety, depression, amphetamine psychosis, suicide, and violent behaviors.
| FactSnippet No. 624,319 |
Methamphetamine is directly neurotoxic to dopaminergic neurons in both lab animals and humans.
| FactSnippet No. 624,320 |
Methamphetamine has been shown to activate TAAR1 in human astrocytes and generate cAMP as a result.
| FactSnippet No. 624,321 |
Methamphetamine that is present in a mother's bloodstream can pass through the placenta to a fetus and be secreted into breast milk.
| FactSnippet No. 624,322 |
Methamphetamine is metabolized by the liver enzyme CYP2D6, so CYP2D6 inhibitors will prolong the elimination half-life of methamphetamine.
| FactSnippet No. 624,323 |
Methamphetamine has been identified as a potent full agonist of trace amine-associated receptor 1, a G protein-coupled receptor (GPCR) that regulates brain catecholamine systems.
| FactSnippet No. 624,324 |
Methamphetamine is an agonist of the alpha-2 adrenergic receptors and sigma receptors with a greater affinity for s1 than s2, and inhibits monoamine oxidase A and monoamine oxidase B (MAO-B).
| FactSnippet No. 624,325 |
Methamphetamine is well absorbed following inhalation and following intranasal administration.
| FactSnippet No. 624,326 |
Methamphetamine is excreted by the kidneys, with the rate of excretion into the urine heavily influenced by urinary pH.
| FactSnippet No. 624,327 |
Methamphetamine has been placed in schedule II of the United Nations Convention on Psychotropic Substances treaty.
| FactSnippet No. 624,328 |